Teva (ADR)
Combines global generics scale with innovative neuroscience and immunology medicines.
$36.30
After-hours close−0.13 (−0.36%)
At close$36.43(−3.16%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | $0.72 | — | — |
| Jul 2026 | $0.08 | $0.02 | −75.0% |
| Apr 2026 | $0.50 | $0.53 | +6.0% |
| Jan 2026 | $0.65 | $0.96 | +47.7% |
| Nov 2025 | $0.68 | $0.78 | +14.7% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||
| Jul 2025 | |||
| May 2025 | |||
| Jan 2025 | |||
| Nov 2024 | |||
| Jul 2024 | |||
| May 2024 | |||
| Jan 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Nov 2022 | |||
| Jul 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Oct 2021 | |||
| Jul 2021 | |||
| Apr 2021 | |||
| Feb 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Feb 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Feb 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Feb 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Feb 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Feb 2016 | |||
| Oct 2015 | |||
| Jul 2015 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 4, 2026 | $0.72 | — | — | $4.23B | — | — |
| Jul 29, 2026 | $0.08 | $0.02 | −75.0% | $4.02B | $4.14B | +3.0% |
| Apr 29, 2026 | $0.50 | $0.53 | +6.0% | $3.79B | $3.98B | +5.1% |
| Jan 28, 2026 | $0.65 | $0.96 | +47.7% | $4.32B | $4.71B | +9.1% |
| Nov 5, 2025 | $0.68 | $0.78 | +14.7% | $4.45B | $4.48B | +0.6% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | ||||||
| Jul 30, 2025 | ||||||
| May 7, 2025 | ||||||
| Jan 29, 2025 | ||||||
| Nov 6, 2024 | ||||||
| Jul 31, 2024 | ||||||
| May 8, 2024 | ||||||
| Jan 31, 2024 | ||||||
| Nov 8, 2023 | ||||||
| Aug 2, 2023 | ||||||
| May 10, 2023 | ||||||
| Feb 8, 2023 | ||||||
| Nov 3, 2022 | ||||||
| Jul 26, 2022 | ||||||
| May 3, 2022 | ||||||
| Feb 9, 2022 | ||||||
| Oct 27, 2021 | ||||||
| Jul 28, 2021 | ||||||
| Apr 28, 2021 | ||||||
| Feb 10, 2021 | ||||||
| Nov 5, 2020 | ||||||
| Aug 5, 2020 | ||||||
| May 7, 2020 | ||||||
| Feb 12, 2020 | ||||||
| Nov 7, 2019 | ||||||
| Aug 7, 2019 | ||||||
| May 2, 2019 | ||||||
| Feb 13, 2019 | ||||||
| Nov 1, 2018 | ||||||
| Aug 2, 2018 | ||||||
| May 3, 2018 | ||||||
| Feb 8, 2018 | ||||||
| Nov 2, 2017 | ||||||
| Aug 3, 2017 | ||||||
| May 11, 2017 | ||||||
| Feb 13, 2017 | ||||||
| Nov 15, 2016 | ||||||
| Aug 4, 2016 | ||||||
| May 9, 2016 | ||||||
| Feb 11, 2016 | ||||||
| Oct 29, 2015 | ||||||
| Jul 30, 2015 | ||||||